Clinical Trials in Denver

Showing 9141-9160 of 13,773 trials

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

NCT02614612

To determine if Itacitinib in combination with corticosteroids is safe and tolerable in patients with Grade IIB-IVD acute graft-versus-host disease (GVHD).

Graft-versus-host Disease (GVHD)

Incyte Corporation31 participantsStarted Dec 2015

Duarte, California, United States • La Jolla, California, United States • Los Angeles, California, United States +20 more locations

COMPLETED< 1 mile

Inflammation and the Host Response to Injury (Trauma)

NCT00257231

The purpose of this study is to help improve our understanding of the biology involved in the body's response to serious trauma or burn injury. The host response to trauma and burns is a collection of physiological and pathophysiological processes that depend critically upon the regulation of the human innate immune system, with particular emphasis on the inflammatory component of that system. No single research center or small group of centers has the capacity to delineate the integrated response of this complex biological system, which involves multiple molecular and genetic interactions that vary in time. Our proposal promotes the identification of important dynamic relationships that regulate the integration of this complex biological system, with the expectation that this understanding will ultimately impact the diagnosis, prognosis, and treatment of the hospitalized, severely injured patient.

TraumaBurnsMultiple Organ Failure

Massachusetts General Hospital610 participantsStarted Nov 2003

Denver, Colorado, United States • Pittsburgh, Pennsylvania, United States • Dallas, Texas, United States +1 more locations

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

Inflammation and the Host Response to Injury (Trauma)

Find Trials by Condition in Denver

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

A Study of LY2928057 in Hemodialysis Participants

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

PEEK and Allograft Spacers Evaluation in Spinal Fusion Surgeries

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors